Literature DB >> 22781396

Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing.

Mee Young Ahn1, Dong O Kang, Yong Jin Na, Sungpil Yoon, Whan Soo Choi, Keun Wook Kang, Hae Young Chung, Jee H Jung, Do Sik Min, Hyung Sik Kim.   

Abstract

This study examined the molecular mechanisms of apicidin in the modulation of human ovarian cancer SKOV-3 cells invasion and migration. Apicidin markedly decreased histone deacetylase 4 (HDAC4) expression and blocked cell migration and invasion. Cell migration was inhibited via down-regulation of matrix metalloproteinase-2 (MMP-2) and up-regulation of RECK in the HDAC4-blocked SKOV-3 cells. Apicidin significantly suppressed the binding of HDAC4 to Sp1 binding elements of the RECK promoter via repression of HDAC4. In an in vivo model, apicidin suppressed the growth of transplanted SKOV-3 cells by down-regulating HDAC4 and MMP-2. Apicidin may potentially be used as an anti-cancer agent for inhibition of cancer cell migration and invasion through the repression of MMP-2 which is related to the reduction of HDAC4.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22781396     DOI: 10.1016/j.canlet.2012.06.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer.

Authors:  Sandeep Kumar; Ajay K Chaudhary; Rahul Kumar; Jordan O'Malley; Anna Dubrovska; Xinjiang Wang; Neelu Yadav; David W Goodrich; Dhyan Chandra
Journal:  Mol Oncol       Date:  2016-03-31       Impact factor: 6.603

2.  Treponema denticola increases MMP-2 expression and activation in the periodontium via reversible DNA and histone modifications.

Authors:  Islam M Ateia; Pimchanok Sutthiboonyapan; Pachiyappan Kamarajan; Taocong Jin; Valentina Godovikova; Yvonne L Kapila; J Christopher Fenno
Journal:  Cell Microbiol       Date:  2018-01-08       Impact factor: 3.715

3.  Kruppel-like factor4 regulates PRDM1 expression through binding to an autoimmune risk allele.

Authors:  Su Hwa Jang; Helen Chen; Peter K Gregersen; Betty Diamond; Sun Jung Kim
Journal:  JCI Insight       Date:  2017-01-12

Review 4.  Toward a Cancer Drug of Fungal Origin.

Authors:  Alexander Kornienko; Antonio Evidente; Maurizio Vurro; Véronique Mathieu; Alessio Cimmino; Marco Evidente; Willem A L van Otterlo; Ramesh Dasari; Florence Lefranc; Robert Kiss
Journal:  Med Res Rev       Date:  2015-04-08       Impact factor: 12.944

5.  Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut.

Authors:  Jiajun Luo; Hang Li; Nicole C Deziel; Huang Huang; Nan Zhao; Shuangge Ma; Xin Ni; Robert Udelsman; Yawei Zhang
Journal:  Environ Res       Date:  2019-12-06       Impact factor: 6.498

Review 6.  Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.

Authors:  Jacob J Russell; Laurel A Grisanti; Scott M Brown; Chastidy A Bailey; Shawn B Bender; B Chandrasekar
Journal:  Cell Signal       Date:  2021-03-27       Impact factor: 4.850

7.  HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review).

Authors:  Xuan Ni; Li Li; Guoyu Pan
Journal:  Oncol Lett       Date:  2014-11-19       Impact factor: 2.967

Review 8.  HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells.

Authors:  Yun Chen; Ya-Hui Tsai; Sheng-Hong Tseng
Journal:  Int J Mol Sci       Date:  2017-01-26       Impact factor: 5.923

9.  Apoptosis signal-regulating kinase 1 is involved in brain-derived neurotrophic factor (BDNF)-enhanced cell motility and matrix metalloproteinase 1 expression in human chondrosarcoma cells.

Authors:  Chih-Yang Lin; Sunny Li-Yun Chang; Yi-Chin Fong; Chin-Jung Hsu; Chih-Hsin Tang
Journal:  Int J Mol Sci       Date:  2013-07-25       Impact factor: 5.923

10.  A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1.

Authors:  Umasankar De; Soma Kundu; Nabanita Patra; Mee Young Ahn; Ji Hae Ahn; Ji Yeon Son; Jung Hyun Yoon; Hyung Ryoung Moon; Byung Mu Lee; Hyung Sik Kim
Journal:  Biomol Ther (Seoul)       Date:  2015-09-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.